http://topics.cnn.com/topics/feeds/rss/Rheumatoid_ArthritisFind stories, videos, and photos about Rheumatoid Arthritis from CNN.com.en-usCable News Network LP, LLLP.Thu, 26 Nov 2009 02:59:38 GMT5http://i.cdn.turner.com/cnn/.element/img/1.0/logo/cnn.logo.rss.gifhttp://topics.cnn.com/topics/feeds/rss/Rheumatoid_Arthritis14433Find stories, videos, and photos about Rheumatoid Arthritis from CNN.com.http://www.cnn.com/2009/HEALTH/expert.q.a/02/25/multiple.sclerosis.medication.brawley/index.html#cnnSTCTexthttp://www.cnn.com/2009/HEALTH/expert.q.a/02/25/multiple.sclerosis.medication.brawley/index.html#cnnSTCTextI am an MS [multiple sclerosis] patient and I have just about had it with my Rebif injections. I've heard about a new leukemia drug used to treat the beginning stages of MS. I think it's called Campath 1H. Are there any other medications you would recommend for early stage MS? Thank you.Wed, 25 Feb 2009 14:55:00 ESThttp://money.cnn.com/2009/01/13/magazines/fortune/investing/investor_daily.fortune/index.htmhttp://money.cnn.com/2009/01/13/magazines/fortune/investing/investor_daily.fortune/index.htmShares of Abbott Laboratories stabilized Tuesday after dropping more than 2% in the previous session when it said it would buy the industry's biggest Lasik vision equipment maker for $2.8 billion.Tue, 13 Jan 2009 20:37:00 ESThttp://money.cnn.com/2008/04/03/news/companies/schering/index.htmhttp://money.cnn.com/2008/04/03/news/companies/schering/index.htmSchering-Plough's stock jumped Thursday, after the drugmaker's chief executive announced he would cut 10% of its staff.Thu, 03 Apr 2008 16:44:00 EDThttp://money.cnn.com/2008/01/24/news/amgen/index.htmhttp://money.cnn.com/2008/01/24/news/amgen/index.htmBiotech Amgen on Thursday reported an increase in earnings and a decrease in sales for the fourth quarter, beating Wall Street's forecast.Thu, 24 Jan 2008 23:05:00 ESThttp://money.cnn.com/2008/01/23/news/companies/abbott/index.htmhttp://money.cnn.com/2008/01/23/news/companies/abbott/index.htmAbbott Laboratories, a maker of drugs and medical devices, reported on Wednesday a jump in sales and earnings that beat Wall Street's estimates.Wed, 23 Jan 2008 15:20:00 ESThttp://money.cnn.com/2007/04/23/news/companies/amgen/index.htmhttp://money.cnn.com/2007/04/23/news/companies/amgen/index.htmThe biotech Amgen reported first-quarter earnings Monday that matched expectations, though its revenue fell just short of forecasts.Mon, 23 Apr 2007 20:11:00 EDThttp://money.cnn.com/2007/04/02/news/companies/abbott/index.htmhttp://money.cnn.com/2007/04/02/news/companies/abbott/index.htmAbbott Laboratories is trying to get its top-selling blockbuster drug approved for yet another use, which could lead to further sales.Mon, 02 Apr 2007 12:36:00 EDThttp://money.cnn.com/2007/01/25/news/companies/amgen/index.htmhttp://money.cnn.com/2007/01/25/news/companies/amgen/index.htmA surge in Amgen Inc's fourth-quarter earnings fell short of analyst projections, but the company's sales topped expectations.Thu, 25 Jan 2007 20:09:00 ESThttp://money.cnn.com/2006/11/22/news/companies/gardasil/index.htmhttp://money.cnn.com/2006/11/22/news/companies/gardasil/index.htmOn the site of a former amusement park in a small Pennsylvania town, technicians sheathed in plastic suits labor over stainless steel fermentation tanks that look like brewery vats.Wed, 22 Nov 2006 15:24:00 ESThttp://money.cnn.com/2006/10/19/news/companies/bigpharma/index.htmhttp://money.cnn.com/2006/10/19/news/companies/bigpharma/index.htmBig Pharma companies Pfizer, Lilly and Wyeth beat analysts' expectations Thursday with reports of strong gains in third-quarter earnings, though Pfizer isn't expecting annual profit growth until 2009 and is ramping up its already ambitious cost-cutting efforts.Thu, 19 Oct 2006 15:36:00 EDThttp://money.cnn.com/2006/08/31/news/companies/abbott/index.htmhttp://money.cnn.com/2006/08/31/news/companies/abbott/index.htmAbbott Labs' fast-growing flagship drug Humira is grabbing market share and making money ... and now the company is trying to win the blessings of the FDA to make more.Thu, 31 Aug 2006 17:26:00 EDThttp://money.cnn.com/2006/08/04/news/companies/ariad/index.htmhttp://money.cnn.com/2006/08/04/news/companies/ariad/index.htmThe bell's about to sound for the next round in a patent fight that the entire pharmaceutical industry is watching.Fri, 04 Aug 2006 18:19:00 EDThttp://money.cnn.com/2006/07/20/news/companies/amgen/index.htmhttp://money.cnn.com/2006/07/20/news/companies/amgen/index.htmAmgen Inc. Thursday reported a surge in second-quarter earnings and sales, soundly beating Wall Street forecasts.Thu, 20 Jul 2006 19:56:00 EDThttp://money.cnn.com/2006/06/27/news/companies/ariad/index.htmhttp://money.cnn.com/2006/06/27/news/companies/ariad/index.htmInvestors, mark your calendars for round 2 of Big Pharma v. biotech.Tue, 27 Jun 2006 16:08:00 EDThttp://money.cnn.com/2006/05/05/news/companies/lilly/index.htmhttp://money.cnn.com/2006/05/05/news/companies/lilly/index.htmA federal jury ruled that Eli Lilly & Co. infringed the patent of Ariad Pharmaceuticals with its drugs Evista and Xigris, and ordered the drugmaker to pay the Massachusetts biotech firm $65.2 million, the companies said.Fri, 05 May 2006 12:16:00 EDThttp://money.cnn.com/2006/02/23/news/companies/drug_sales/index.htmhttp://money.cnn.com/2006/02/23/news/companies/drug_sales/index.htmDrug sales, bolstered by Medicare coverage, are projected to keep rising for the next 10 years, and biotechs are expected to get the lion's share of that increase, while the more traditional Big Pharma companies get squeezed by generic drug makers.Thu, 23 Feb 2006 14:21:00 ESThttp://money.cnn.com/2005/08/23/news/fortune500/bristol/index.htmhttp://money.cnn.com/2005/08/23/news/fortune500/bristol/index.htmBristol-Myers Squibb faces votes by FDA advisory panels on two key drugs in its pipeline, decisions that could affect the company's financial future for years to come.Tue, 23 Aug 2005 17:36:00 EDThttp://www.cnn.com/2005/HEALTH/07/28/journal.roundup/index.htmlhttp://www.cnn.com/2005/HEALTH/07/28/journal.roundup/index.htmlNo comfort for coldsThu, 28 Jul 2005 17:01:00 EDThttp://www.cnn.com/2005/HEALTH/06/21/cancer.nanotech/index.htmlhttp://www.cnn.com/2005/HEALTH/06/21/cancer.nanotech/index.htmlScientists using nanotechnology have devised a way of delivering cancer drugs that could make them up to 10 times more effective in combating the killer disease.Tue, 21 Jun 2005 10:59:00 EDThttp://money.cnn.com/2005/05/03/news/fortune500/blackbox/index.htmhttp://money.cnn.com/2005/05/03/news/fortune500/blackbox/index.htmThe black box label is the most potent warning in the Food and Drug Administration's arsenal, but it is not necessarily a death knell for drug sales, analysts say.Tue, 03 May 2005 14:48:00 EDThttp://money.cnn.com/2005/04/29/news/international/sativex/index.htmhttp://money.cnn.com/2005/04/29/news/international/sativex/index.htmA cannabis-based painkiller for sufferers of multiple sclerosis is expected to be in Canadian pharmacies this summer, but whether it appears on U.S. pharmacy shelves is a key question.Fri, 29 Apr 2005 16:41:00 EDThttp://money.cnn.com/2005/04/06/news/international/roche/index.htmhttp://money.cnn.com/2005/04/06/news/international/roche/index.htmTwo drug candidates that would reduce the symptoms of rheumatoid arthritis have passed testing, announced drug manufacturers Human Genome Sciences, Roche, Genentech and Biogen Idec on Wednesday, offering hope where arthritis treatments have raised health concerns.Wed, 06 Apr 2005 13:11:00 EDThttp://www.cnn.com/2004/HEALTH/conditions/10/08/drug.warning/index.htmlhttp://www.cnn.com/2004/HEALTH/conditions/10/08/drug.warning/index.htmlJohnson & Johnson says its rheumatoid arthritis drug Remicade may put patients at higher risk for lymphoma, and the company is sending out warning letters to physicians.Fri, 08 Oct 2004 14:53:00 EDThttp://money.cnn.com/magazines/fortune/fortune_archive/2004/09/06/380337/index.htmhttp://money.cnn.com/magazines/fortune/fortune_archive/2004/09/06/380337/index.htmA common thread connects this year's standouts: They all responded to crisis by radically changing the way they make things. Autoliv reprocessed its factory to fend off stiff competition in airbags...Mon, 06 Sep 2004 04:01:00 EDThttp://money.cnn.com/magazines/fortune/fortune_archive/2004/05/03/368529/index.htmhttp://money.cnn.com/magazines/fortune/fortune_archive/2004/05/03/368529/index.htmThe Empire State ballroom at the Grand Hyatt Hotel in midtown Manhattan typically serves as the setting for the kind of stuffy, state-of-a-business luncheons that are more snooze inducing than buzz...Mon, 03 May 2004 04:01:00 EDThttp://money.cnn.com/2004/04/06/commentary/mkcommentary/sivy/index.htmhttp://money.cnn.com/2004/04/06/commentary/mkcommentary/sivy/index.htmNokia's disappointing sales announcement and the resulting fallout in the tech sector makes a lot of nervous investors even jumpier. In particular, they fear that any earnings disappointments during the next few weeks may lead to sudden selloffs.Tue, 06 Apr 2004 21:43:00 EDThttp://www.cnn.com/2004/WORLD/europe/01/21/uk.cannabis/index.htmlhttp://www.cnn.com/2004/WORLD/europe/01/21/uk.cannabis/index.htmlA cannabis-based medicine for multiple sclerosis sufferers could be available on prescription in Britain by the summer, according to its manufacturer.Wed, 21 Jan 2004 12:42:00 ESThttp://money.cnn.com/magazines/moneymag/moneymag_archive/2003/02/01/336130/index.htmhttp://money.cnn.com/magazines/moneymag/moneymag_archive/2003/02/01/336130/index.htmScientist Eugene Sun remembers exactly how his boss at Abbott Laboratories responded some years ago to Sun's report on his breakthrough AIDS drug, Kaletra: "I'm tired of hearing about science, I wa...Sat, 01 Feb 2003 05:01:00 ESThttp://money.cnn.com/magazines/fortune/fortune_archive/2002/04/15/321395/index.htmhttp://money.cnn.com/magazines/fortune/fortune_archive/2002/04/15/321395/index.htmFor years Amgen has seemed biotechnology's best answer to the likes of Merck--a sector leader with so much heft and momentum that you'd recommend its stock to your mom. But now making that analogy ...Mon, 15 Apr 2002 04:01:00 EDThttp://money.cnn.com/magazines/fortune/fortune_archive/2001/05/28/303868/index.htmhttp://money.cnn.com/magazines/fortune/fortune_archive/2001/05/28/303868/index.htmPatients who want the rheumatoid arthritis-fighting drug Enbrel have to show a special card to their pharmacist, who then verifies that the patient is enrolled in the Enbrel program before dispensi...Mon, 28 May 2001 04:01:00 EDThttp://money.cnn.com/magazines/moneymag/moneymag_archive/1999/04/01/257677/index.htmhttp://money.cnn.com/magazines/moneymag/moneymag_archive/1999/04/01/257677/index.htmLike any good family practitioner, Dr. Reginald Parker believes in protecting against loss. So he begins his financial exams with some basic questions: What stocks do the mutual funds own? What ind...Thu, 01 Apr 1999 05:01:00 ESThttp://money.cnn.com/magazines/fortune/fortune_archive/1997/10/27/233326/index.htmhttp://money.cnn.com/magazines/fortune/fortune_archive/1997/10/27/233326/index.htmFREEING A MICROSOFT SLAVE Mon, 27 Oct 1997 05:01:00 EST